Functional E3 ligase hotspots and resistance mechanisms to small-molecule degraders

被引:55
作者
Hanzl, Alexander [1 ]
Casement, Ryan [2 ]
Imrichova, Hana [1 ]
Hughes, Scott J. [2 ,3 ]
Barone, Eleonora [1 ]
Testa, Andrea [2 ,3 ]
Bauer, Sophie [1 ,4 ]
Wright, Jane [2 ]
Brand, Matthias [1 ,4 ]
Ciulli, Alessio [2 ]
Winter, Georg E. [1 ]
机构
[1] Austrian Acad Sci, CeMM Res Ctr Mol Med, Vienna, Austria
[2] Univ Dundee, James Black Ctr, Sch Life Sci, Div Biol Chem & Drug Discovery, Dundee, Scotland
[3] Amphista Therapeut Ltd, Newhouse, Scotland
[4] Proxygen GmbH, Vienna, Austria
基金
欧洲研究理事会; 英国惠康基金; 奥地利科学基金会; 英国生物技术与生命科学研究理事会;
关键词
TARGETED PROTEIN-DEGRADATION; UBIQUITIN LIGASE; STRUCTURAL BASIS; IDENTIFICATION; OPTIMIZATION; INHIBITORS; TOOLKIT; DESIGN;
D O I
10.1038/s41589-022-01177-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Targeted protein degradation is a novel pharmacology established by drugs that recruit target proteins to E3 ubiquitin ligases. Based on the structure of the degrader and the target, different E3 interfaces are critically involved, thus forming defined 'functional hotspots'. Understanding disruptive mutations in functional hotspots informs on the architecture of the assembly, and highlights residues susceptible to acquire resistance phenotypes. Here we employ haploid genetics to show that hotspot mutations cluster in substrate receptors of hijacked ligases, where mutation type and frequency correlate with gene essentiality. Intersection with deep mutational scanning revealed hotspots that are conserved or specific for chemically distinct degraders and targets. Biophysical and structural validation suggests that hotspot mutations frequently converge on altered ternary complex assembly. Moreover, we validated hotspots mutated in patients that relapse from degrader treatment. In sum, we present a fast and widely accessible methodology to characterize small-molecule degraders and associated resistance mechanisms.
引用
收藏
页码:323 / +
页数:26
相关论文
共 50 条
  • [1] Small-Molecule Targeting of E3 Ligase Adaptor SPOP in Kidney Cancer
    Guo, Zhong-Qiang
    Zheng, Tong
    Chen, Baoen
    Luo, Cheng
    Ouyang, Sisheng
    Gong, Shouzhe
    Li, Jiafei
    Mao, Liu-Liang
    Lian, Fulin
    Yang, Yong
    Huang, Yue
    Li, Li
    Lu, Jing
    Zhang, Bidong
    Zhou, Luming
    Ding, Hong
    Gao, Zhiwei
    Zhou, Liqun
    Li, Guoqiang
    Zhou, Ran
    Chen, Ke
    Liu, Jingqiu
    Wen, Yi
    Gong, Likun
    Ke, Yuwen
    Yang, Shang-Dong
    Qiu, Xiao-Bo
    Zhang, Naixia
    Ren, Jin
    Zhong, Dafang
    Yang, Cai-Guang
    Liu, Jiang
    Jiang, Hualiang
    CANCER CELL, 2016, 30 (03) : 474 - 484
  • [2] Small-Molecule Inhibitors of the Interaction between the E3 Ligase VHL and HIF1a
    Buckley, Dennis L.
    Gustafson, Jeffrey L.
    Van Molle, Inge
    Roth, Anke G.
    Tae, Hyun Seop
    Gareiss, Peter C.
    Jorgensen, William L.
    Ciulli, Alessio
    Crews, Craig M.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2012, 51 (46) : 11463 - 11467
  • [3] Targeting TRAF6 E3 ligase activity with a small-molecule inhibitor combats autoimmunity
    Brenke, Jara K.
    Popowicz, Grzegorz M.
    Schorpp, Kenji
    Rothenaigner, Ina
    Roesner, Manfred
    Meininger, Isabel
    Kalinski, Cedric
    Ringelstetter, Larissa
    R'kyek, Omar
    Juerjens, Gerrit
    Vincendeau, Michelle
    Plettenburg, Oliver
    Sattler, Michael
    Krappmann, Daniel
    Hadian, Kamyar
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (34) : 13191 - 13203
  • [4] E3 ligase ligand chemistries: from building blocks to protein degraders
    Sosic, Izidor
    Bricelj, Alesa
    Steinebach, Christian
    CHEMICAL SOCIETY REVIEWS, 2022, 51 (09) : 3487 - 3534
  • [5] Homo-PROTACs: bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation
    Maniaci, Chiara
    Hughes, Scott J.
    Testa, Andrea
    Chen, Wenzhang
    Lamont, Douglas J.
    Rocha, Sonia
    Alessi, Dario R.
    Romeo, Roberto
    Ciulli, Alessio
    NATURE COMMUNICATIONS, 2017, 8
  • [6] An E3 ligase guide to the galaxy of small-molecule-induced protein degradation
    Jevtic, Predrag
    Haakonsen, Diane L.
    Rape, Michael
    CELL CHEMICAL BIOLOGY, 2021, 28 (07) : 1000 - 1013
  • [7] QSAR modeling and in silico design of small-molecule inhibitors targeting the interaction between E3 ligase VHL and HIF-1α
    Pan, Jing
    Zhang, Yanmin
    Ran, Ting
    Xu, Anyang
    Qiao, Xin
    Yin, Lingfeng
    Zhou, Weineng
    Zhu, Lu
    Zhao, Junnan
    Lu, Tao
    Chen, Yadong
    Jiang, Yulei
    MOLECULAR DIVERSITY, 2017, 21 (03) : 719 - 739
  • [8] Methods to Detect Small Molecule Inhibition of RING E3 Ligase Activity
    Rothenaigner, Ina
    Brenke, Jara Kerstin
    Schorpp, Kenji
    Hadian, Kamyar
    CURRENT PROTOCOLS, 2022, 2 (04):
  • [9] Discovery of Highly Potent and Efficient PROTAC Degraders of Androgen Receptor (AR) by Employing Weak Binding Affinity VHL E3 Ligase Ligands
    Han, Xin
    Zhao, Lijie
    Xiang, Weiguo
    Qin, Chong
    Miao, Bukeyan
    Xu, Tianfeng
    Wang, Mi
    Yang, Chao-Yie
    Chinnaswamy, Krishnapriya
    Stuckey, Jeanne
    Wang, Shaomeng
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (24) : 11218 - 11231
  • [10] Development of Small Molecule Chimeras That Recruit AhR E3 Ligase to Target Proteins
    Ohoka, Nobumichi
    Tsuji, Genichiro
    Shoda, Takuji
    Fujisato, Takuma
    Kurihara, Masaaki
    Demizu, Yosuke
    Naito, Mikihiko
    ACS CHEMICAL BIOLOGY, 2019, 14 (12) : 2822 - 2832